{"product_id":"ame-bcg-matrix","title":"AMETEK, Inc. (AME): BCG Matrix [June-2026 Updated]","description":"\u003cp\u003eThis ready-made BCG Matrix Analysis of AMETEK, Inc. Business gives you a clear, research-based view of where the portfolio is growing, where it throws off cash, and where capital may be best deployed. You'll see why Electronic Instruments Group looks like the main growth engine with about \u003cstrong\u003e$5.00B\u003c\/strong\u003e of 2025 sales and Q1 2026 sales up \u003cstrong\u003e11.0%\u003c\/strong\u003e, why Electromechanical Group acts as a cash cow with about \u003cstrong\u003e$2.40B\u003c\/strong\u003e of 2025 sales and a \u003cstrong\u003e22.7%\u003c\/strong\u003e Q4 margin, and how recent acquisitions such as FARO, Kern Microtechnik, LKC Technologies, First Aviation Services, and the \u003cstrong\u003e$5.0B\u003c\/strong\u003e Indicor deal fit into the company's capital-allocation strategy. It also helps you assess portfolio balance using real figures such as \u003cstrong\u003e$7.40B\u003c\/strong\u003e of 2025 sales, \u003cstrong\u003e$1.70B\u003c\/strong\u003e of free cash flow, \u003cstrong\u003e26.2%\u003c\/strong\u003e adjusted operating margin, and the absence of a clear dog segment as of June 2026.\u003c\/p\u003e\u003ch2\u003eAMETEK, Inc. - BCG Matrix Analysis: Stars\u003c\/h2\u003e\n\n\u003cp\u003eAMETEK's Star businesses are its fastest-growing, highest-quality platforms, especially the Electronic Instruments Group. These units combine strong market demand, high margins, and recurring revenue, which is exactly what you want in a Star category. The key point is that AMETEK is not chasing low-quality growth; it is buying and building businesses with durable pricing power and technical depth.\u003c\/p\u003e\n\n\u003cp\u003eElectronic Instruments Group is the clearest Star. It generated about \u003cstrong\u003e$5.00B\u003c\/strong\u003e of 2025 sales, or roughly \u003cstrong\u003e68%\u003c\/strong\u003e of total company revenue. In Q1 2026, EIG sales rose \u003cstrong\u003e11.0%\u003c\/strong\u003e year over year to \u003cstrong\u003e$1.26B\u003c\/strong\u003e. Orders were even stronger, reaching \u003cstrong\u003e$2.20B\u003c\/strong\u003e, up \u003cstrong\u003e23%\u003c\/strong\u003e, with organic orders up \u003cstrong\u003e22%\u003c\/strong\u003e. Backlog climbed to a record \u003cstrong\u003e$3.87B\u003c\/strong\u003e at March 31, 2026. That matters because backlog gives you visibility into future sales and supports the case that this segment is still in a growth phase rather than a mature cash cow.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eStar driver\u003c\/td\u003e\n\u003ctd\u003eRecent data point\u003c\/td\u003e\n\u003ctd\u003eWhy it matters\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eElectronic Instruments Group sales\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$5.00B\u003c\/strong\u003e in 2025\u003c\/td\u003e\n\u003ctd\u003eLargest growth platform and core revenue engine\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 2026 EIG sales growth\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e11.0%\u003c\/strong\u003e year over year to \u003cstrong\u003e$1.26B\u003c\/strong\u003e\n\u003c\/td\u003e\n \u003ctd\u003eShows demand momentum is still strong\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 2026 orders\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$2.20B\u003c\/strong\u003e, up \u003cstrong\u003e23%\u003c\/strong\u003e\n\u003c\/td\u003e\n \u003ctd\u003eSignals future revenue conversion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBacklog\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$3.87B\u003c\/strong\u003e at March 31, 2026\u003c\/td\u003e\n \u003ctd\u003eImproves revenue visibility and planning\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct vitality index\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e26%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows innovation from products launched in the last three years\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eAMETEK's niche strategy makes the Star profile stronger. The company focuses on markets with high barriers to entry, differentiated technology, and recurring revenue from consumables, services, and aftermarket support. That mix protects margins and reduces the risk of commoditization. In 2025, adjusted operating income reached \u003cstrong\u003e$1.94B\u003c\/strong\u003e, and the adjusted operating margin was \u003cstrong\u003e26.2%\u003c\/strong\u003e. Full-year 2025 sales were \u003cstrong\u003e$7.40B\u003c\/strong\u003e, up \u003cstrong\u003e6.6%\u003c\/strong\u003e, while adjusted diluted EPS rose \u003cstrong\u003e9%\u003c\/strong\u003e to \u003cstrong\u003e$7.43\u003c\/strong\u003e. High margins plus growth is the classic Star combination because it shows the business can expand without giving up profitability.\u003c\/p\u003e\n\n\u003cp\u003eThe company is still funding growth, which is important for a Star. AMETEK spent \u003cstrong\u003e$85M\u003c\/strong\u003e on incremental innovation and market-expansion efforts in 2025, and 2026 capital expenditures are guided at about \u003cstrong\u003e$160M\u003c\/strong\u003e. This is not a maintenance-only spending pattern. It suggests management is still building technical capabilities, production capacity, and market reach. For academic analysis, this is a useful sign that the company is trying to extend the life of its growth franchises rather than squeeze short-term earnings.\u003c\/p\u003e\n\n\u003cp\u003eDefense and automation are also supporting Star-like growth. AMETEK cited sustained demand in defense aftermarket, aerospace platforms, and advanced industrial automation as a 2026 tailwind. Q1 2026 net income was \u003cstrong\u003e$399.4M\u003c\/strong\u003e, and adjusted diluted EPS was \u003cstrong\u003e$1.97\u003c\/strong\u003e, up \u003cstrong\u003e13%\u003c\/strong\u003e from \u003cstrong\u003e$1.75\u003c\/strong\u003e a year earlier. The company also reported only about \u003cstrong\u003e2%\u003c\/strong\u003e of total sales from the Middle East, which lowers concentration risk. That matters because a Star should grow in resilient end markets, not depend on one volatile region or customer group.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eDefense aftermarket supports recurring service demand.\u003c\/li\u003e\n \u003cli\u003eAerospace platforms create long product lifecycles and follow-on revenue.\u003c\/li\u003e\n \u003cli\u003eIndustrial automation benefits from long-term productivity investment.\u003c\/li\u003e\n \u003cli\u003eLow Middle East exposure reduces geographic concentration risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eAI and R\u0026amp;D strengthen the Star case further. AMETEK's June 2026 strategy explicitly names AI integration as a primary driver of long-term growth and competitive positioning. R\u0026amp;D is being directed toward mission-critical applications in medical, aerospace, defense, and automation. The company's 2025 sustainability and innovation disclosures show a willingness to fund transformation rather than simply manage mature assets. That matters in the BCG Matrix because Stars need reinvestment to defend market share while markets are still expanding.\u003c\/p\u003e\n\n\u003cp\u003eAMETEK's balance sheet and market support also reinforce the Star profile. Its market capitalization was about \u003cstrong\u003e$55.30B\u003c\/strong\u003e, institutional ownership stood near \u003cstrong\u003e87.43%\u003c\/strong\u003e, and capital deployment capacity was above \u003cstrong\u003e$5.0B\u003c\/strong\u003e. High institutional ownership often reflects confidence in earnings durability, while strong capital capacity gives management room to keep buying growth. For students writing about BCG analysis, this is a good example of how financial strength supports strategic execution in a Star category.\u003c\/p\u003e\n\n\u003cp\u003eAcquisitions are a major part of AMETEK's Star-building strategy. The company completed FARO Technologies in July 2025 for \u003cstrong\u003e$920.0M\u003c\/strong\u003e and Kern Microtechnik in January 2025 for \u003cstrong\u003e$51.6M\u003c\/strong\u003e. It also announced LKC Technologies in February 2026 and First Aviation Services in May 2026, while agreeing in May 2026 to buy Indicor's instrumentation portfolio for about \u003cstrong\u003e$5.0B\u003c\/strong\u003e in cash. Indicor generated about \u003cstrong\u003e$1.10B\u003c\/strong\u003e of 2025 sales and was valued at \u003cstrong\u003e14x EBITDA\u003c\/strong\u003e. That is a large, deliberate bet on higher-growth niches, not a harvesting move.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eFARO Technologies acquisition: \u003cstrong\u003e$920.0M\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eKern Microtechnik acquisition: \u003cstrong\u003e$51.6M\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eFirst Aviation Services annual revenue: about \u003cstrong\u003e$80M\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eIndicor portfolio purchase price: about \u003cstrong\u003e$5.0B\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eIndicor 2025 sales: about \u003cstrong\u003e$1.10B\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003e2025 acquisition spending: \u003cstrong\u003e$933.2M\u003c\/strong\u003e net of cash acquired\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis acquisition cadence supports a Star classification because AMETEK is using capital to expand into technical, recurring, and high-barrier markets. In BCG terms, Stars need both market growth and strong relative market position. AMETEK's EIG segment, aerospace and defense exposure, innovation spending, and acquisition pace all point to businesses that can keep growing while holding or improving their competitive position.\u003c\/p\u003e\u003ch2\u003eAMETEK, Inc. - BCG Matrix Analysis: Cash Cows\u003c\/h2\u003e\n\n\u003cp\u003eAMETEK's Electromechanical Group fits the BCG Cash Cow category because it combines scale, strong margins, and recurring demand with relatively modest capital needs. This business generates reliable cash that can fund acquisitions, dividends, and balance-sheet discipline across the broader portfolio.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eEMG Cash Yield\u003c\/strong\u003e is the clearest sign of Cash Cow strength. Electromechanical Group produced about \u003cstrong\u003e$2.40B\u003c\/strong\u003e of 2025 sales, equal to roughly \u003cstrong\u003e32%\u003c\/strong\u003e of company revenue. Q4 2025 EMG sales rose \u003cstrong\u003e15%\u003c\/strong\u003e year over year to \u003cstrong\u003e$628.9M\u003c\/strong\u003e, while operating margin expanded by \u003cstrong\u003e240 basis points\u003c\/strong\u003e to \u003cstrong\u003e22.7%\u003c\/strong\u003e. International sales made up \u003cstrong\u003e41%\u003c\/strong\u003e of EMG net sales, which shows a wide installed base and broad customer reach. A business with this kind of scale and margin usually sits in the mature, high-cash part of a BCG portfolio.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eCash Cow Indicator\u003c\/th\u003e\n\u003cth\u003eAMETEK Data\u003c\/th\u003e\n\u003cth\u003eWhy It Matters\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEMG 2025 sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.40B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLarge revenue base supports steady cash generation\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eShare of company revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e32%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows EMG is a major contributor to the portfolio\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ4 2025 sales growth\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e15%\u003c\/strong\u003e year over year\u003c\/td\u003e\n\u003ctd\u003eSignals continued demand without needing a high-risk growth bet\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ4 2025 operating margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e22.7%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigh profitability turns revenue into cash\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational sales mix\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e41%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSuggests a diversified, globally embedded installed base\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eFree Cash Flow Machine\u003c\/strong\u003e is the second reason EMG belongs in Cash Cows. Full-year 2025 free cash flow was \u003cstrong\u003e$1.70B\u003c\/strong\u003e, and net income conversion was \u003cstrong\u003e113%\u003c\/strong\u003e. That means AMETEK turned accounting profit into even more cash than reported earnings, which is a sign of strong working-capital control and efficient operations. For 2026, free cash flow conversion is expected to stay at \u003cstrong\u003e110%\u003c\/strong\u003e to \u003cstrong\u003e115%\u003c\/strong\u003e of net income. Full-year 2025 net income reached \u003cstrong\u003e$1.48B\u003c\/strong\u003e, up \u003cstrong\u003e7.56%\u003c\/strong\u003e year over year, and adjusted diluted EPS was \u003cstrong\u003e$7.43\u003c\/strong\u003e. The company also raised full-year 2026 adjusted EPS guidance to \u003cstrong\u003e$7.94\u003c\/strong\u003e to \u003cstrong\u003e$8.14\u003c\/strong\u003e, which supports the view that cash generation remains durable.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 free cash flow: \u003cstrong\u003e$1.70B\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eNet income conversion: \u003cstrong\u003e113%\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003e2026 expected free cash flow conversion: \u003cstrong\u003e110%\u003c\/strong\u003e to \u003cstrong\u003e115%\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003e2025 net income: \u003cstrong\u003e$1.48B\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003e2025 adjusted diluted EPS: \u003cstrong\u003e$7.43\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003e2026 adjusted EPS guidance: \u003cstrong\u003e$7.94\u003c\/strong\u003e to \u003cstrong\u003e$8.14\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eInstalled Base Services\u003c\/strong\u003e strengthen the Cash Cow profile because recurring revenue is easier to defend than one-time equipment sales. AMETEK's revenue base comes from consumables, services, and aftermarket support, which usually repeat across long customer relationships. The company operates more than \u003cstrong\u003e220\u003c\/strong\u003e manufacturing sites worldwide and employs about \u003cstrong\u003e21,500\u003c\/strong\u003e people, giving it the scale to service a large installed base efficiently. Operating working capital was \u003cstrong\u003e16.5%\u003c\/strong\u003e of sales in Q1 2026, improving by \u003cstrong\u003e30 basis points\u003c\/strong\u003e year over year. AMETEK also paid \u003cstrong\u003e$425M\u003c\/strong\u003e of debt maturities in 2025 while still supporting investment-grade credit retention, which matters because it shows the cash engine is strong enough to reduce obligations and still invest.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMargin Discipline\u003c\/strong\u003e is central to why this business fits the Cash Cow slot. AMETEK's adjusted operating margin for 2025 was \u003cstrong\u003e26.2%\u003c\/strong\u003e, which is high for an industrial company of this size. GAAP operating income was \u003cstrong\u003e$1.91B\u003c\/strong\u003e, and adjusted operating income was \u003cstrong\u003e$1.94B\u003c\/strong\u003e, so the results were not heavily distorted by unusual items. Q1 2026 sales were \u003cstrong\u003e$1.93B\u003c\/strong\u003e, up \u003cstrong\u003e11.3%\u003c\/strong\u003e, showing that the cash base can still grow without heavy capital intensity. 2026 capex is guided at about \u003cstrong\u003e$160M\u003c\/strong\u003e, or roughly \u003cstrong\u003e2%\u003c\/strong\u003e of sales, which is modest and leaves more cash available for acquisitions, buybacks, and dividends.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eProfitability and Cash Metrics\u003c\/th\u003e\n\u003cth\u003e2025 \/ 2026 Data\u003c\/th\u003e\n\u003cth\u003eInterpretation\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdjusted operating margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e26.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStrong industrial profitability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAAP operating income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.91B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows scale and earnings quality\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdjusted operating income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.94B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eConfirms limited one-off distortion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 2026 sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.93B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows continued expansion of the cash base\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2026 capex guidance\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$160M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLow capital spending supports free cash flow\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex as a share of sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSignals efficient capital use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eDividend Support\u003c\/strong\u003e is another Cash Cow feature. AMETEK raised its quarterly cash dividend by \u003cstrong\u003e10%\u003c\/strong\u003e to \u003cstrong\u003e$0.34\u003c\/strong\u003e per share in February 2026. That move was supported by 2025 adjusted diluted EPS of \u003cstrong\u003e$7.43\u003c\/strong\u003e and free cash flow of \u003cstrong\u003e$1.70B\u003c\/strong\u003e. Institutional ownership was about \u003cstrong\u003e87.43%\u003c\/strong\u003e, while insiders held \u003cstrong\u003e0.66%\u003c\/strong\u003e, which reflects a widely held company with a stable cash profile. With a market capitalization of about \u003cstrong\u003e$55.30B\u003c\/strong\u003e, investors are clearly pricing in dependable earnings and cash generation rather than speculative growth. In BCG terms, this is exactly the kind of mature business that can fund the rest of the portfolio.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eQuarterly dividend increase: \u003cstrong\u003e10%\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eNew quarterly dividend: \u003cstrong\u003e$0.34\u003c\/strong\u003e per share\u003c\/li\u003e\n \u003cli\u003eInstitutional ownership: \u003cstrong\u003e87.43%\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eInsider ownership: \u003cstrong\u003e0.66%\u003c\/strong\u003e\n\u003c\/li\u003e\n \u003cli\u003eMarket capitalization: \u003cstrong\u003e$55.30B\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy it matters for BCG analysis\u003c\/strong\u003e is straightforward. Cash Cows should generate more cash than they need for maintenance investment, and AMETEK's Electromechanical Group does that through high margins, recurring demand, global distribution, and low capex intensity. That cash supports growth initiatives elsewhere in the portfolio, especially acquisitions and shareholder returns, while reducing pressure on the balance sheet.\u003c\/p\u003e\n\u003ch2\u003eAMETEK, Inc. - BCG Matrix Analysis: Question Marks\u003c\/h2\u003e\n\n\u003cp\u003eAMETEK's Question Marks are the newest acquisitions and niche platforms that can grow into stronger positions, but they still lack enough scale, disclosed share data, or proven earnings contribution. They matter because they show where AMETEK is spending capital to build future growth, even if the payoff is not yet visible in reported results.\u003c\/p\u003e\n\n\u003cp\u003eIn BCG terms, a Question Mark sits in a high-growth area but holds a weak or unproven market position. That creates strategic tension: the business can become a Star if AMETEK gains share, or it can stay small and consume capital without delivering enough return. For academic analysis, this part of the portfolio is where you test execution risk, integration risk, and capital allocation discipline.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eBusiness\u003c\/th\u003e\n\u003cth\u003eTransaction Date\u003c\/th\u003e\n\u003cth\u003eKnown Scale\u003c\/th\u003e\n\u003cth\u003eWhy It Fits Question Marks\u003c\/th\u003e\n\u003cth\u003eStrategic Issue\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndicor portfolio\u003c\/td\u003e\n\u003ctd\u003eMay 6, 2026\u003c\/td\u003e\n\u003ctd\u003eAbout \u003cstrong\u003e$5.0B\u003c\/strong\u003e cash purchase; about \u003cstrong\u003e$1.10B\u003c\/strong\u003e of 2025 sales; priced at \u003cstrong\u003e14x EBITDA\u003c\/strong\u003e\n\u003c\/td\u003e\n \u003ctd\u003eLarge deal, not yet closed, no integration results in AMETEK's reported numbers\u003c\/td\u003e\n \u003ctd\u003eShare gains and margin expansion must appear after closing in H2 2026\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLKC Technologies\u003c\/td\u003e\n\u003ctd\u003eFebruary 3, 2026\u003c\/td\u003e\n\u003ctd\u003ePurchase price and annual revenue not disclosed\u003c\/td\u003e\n \u003ctd\u003eSpecialized medical niche with unclear market share and scale\u003c\/td\u003e\n \u003ctd\u003eNeeds product adoption and clinical demand to prove its role\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFirst Aviation Services\u003c\/td\u003e\n\u003ctd\u003eMay 26, 2026\u003c\/td\u003e\n\u003ctd\u003eAbout \u003cstrong\u003e$80.0M\u003c\/strong\u003e in annual revenue\u003c\/td\u003e\n \u003ctd\u003eSmall versus AMETEK's \u003cstrong\u003e$7.40B\u003c\/strong\u003e 2025 sales base, or about \u003cstrong\u003e1.1%\u003c\/strong\u003e\n\u003c\/td\u003e\n \u003ctd\u003eStrong sector demand exists, but scale is still too small to re-rate the business\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFARO Technologies\u003c\/td\u003e\n\u003ctd\u003eJuly 2025\u003c\/td\u003e\n\u003ctd\u003eAcquired for \u003cstrong\u003e$920.0M\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003e3D measurement and imaging fits automation and technology themes, but no standalone post-deal results are disclosed\u003c\/td\u003e\n \u003ctd\u003eIntegration quality will decide whether it moves toward Star status\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKern Microtechnik\u003c\/td\u003e\n\u003ctd\u003eJanuary 2025\u003c\/td\u003e\n\u003ctd\u003eAcquired for \u003cstrong\u003e$51.6M\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHigh-precision machining is strategically attractive, but the business is still small against AMETEK's size\u003c\/td\u003e\n \u003ctd\u003eNeeds faster revenue contribution to justify capital use\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eIndicor portfolio\u003c\/strong\u003e is the clearest Question Mark. AMETEK agreed on May 6, 2026 to buy a portfolio of instrumentation businesses for about \u003cstrong\u003e$5.0B\u003c\/strong\u003e in cash. The target generated about \u003cstrong\u003e$1.10B\u003c\/strong\u003e of 2025 sales and was priced at \u003cstrong\u003e14x EBITDA\u003c\/strong\u003e, which signals that AMETEK is paying for quality and expected synergy, not just current earnings. Closing is expected in H2 2026, so the deal is not yet visible in reported revenue, margin, or cash flow. Management also said capital deployment capacity still exceeds \u003cstrong\u003e$5.0B\u003c\/strong\u003e, which shows that the company is willing to make a major bet. Until the integration works and market share improves, this is still a large Question Mark, not a proven core asset.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eLKC Technologies\u003c\/strong\u003e is another Question Mark because it sits in a specialized medical niche with limited disclosure. AMETEK announced the acquisition on February 3, 2026, but it has not disclosed the purchase price or annual revenue. That makes it hard to measure market share, which is one of the key tests in the BCG Matrix. The product line in pediatric and adult ophthalmology may have strong technical value, but without scale data, you cannot yet call it a Star. AMETEK's 2025 innovation spend rose by \u003cstrong\u003e$85.0M\u003c\/strong\u003e, and the vitality index reached \u003cstrong\u003e26%\u003c\/strong\u003e, so the company is clearly funding new product growth. That internal support matters because Question Marks need investment before they can earn a leading position.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic upside:\u003c\/strong\u003e if clinical adoption rises, the business can move from niche presence to stronger market position.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eStrategic risk:\u003c\/strong\u003e if revenue stays small, it may remain a capital consumer.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eAcademic angle:\u003c\/strong\u003e this is a good example of how innovation spending supports future portfolio growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFirst Aviation Services\u003c\/strong\u003e is a Question Mark because the revenue base is still too small relative to AMETEK's scale. AMETEK completed the acquisition on May 26, 2026, and First Aviation has about \u003cstrong\u003e$80.0M\u003c\/strong\u003e in annual revenue. Compared with AMETEK's \u003cstrong\u003e$7.40B\u003c\/strong\u003e 2025 sales base, that is only about \u003cstrong\u003e1.1%\u003c\/strong\u003e of group revenue. The business operates in defense and aviation MRO, where demand can be attractive because aircraft need maintenance even when new plane production slows. But AMETEK has not disclosed the acquisition's contribution to earnings or margins, so the market still lacks proof of operating leverage. The small size keeps it in Question Mark territory, even if the end market is healthy.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFARO Technologies\u003c\/strong\u003e is an integration-driven Question Mark. AMETEK acquired it in July 2025 for \u003cstrong\u003e$920.0M\u003c\/strong\u003e, bringing in 3D measurement and imaging solutions that fit the company's automation and technology themes. AMETEK reported strong Q1 2026 orders of \u003cstrong\u003e$2.20B\u003c\/strong\u003e and a record backlog of \u003cstrong\u003e$3.87B\u003c\/strong\u003e, which suggests the broader business has enough activity to support integration. Still, no standalone post-acquisition revenue or market share has been disclosed as of June 2026. That means the asset has strategic logic, but the evidence is not yet strong enough to classify it as a Star. It remains a Question Mark because the next stage depends on execution, not just purchase price.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eKern Microtechnik\u003c\/strong\u003e is small but strategically relevant. AMETEK acquired Kern in January 2025 for \u003cstrong\u003e$51.6M\u003c\/strong\u003e, and the business provides high-precision machining solutions that fit AMETEK's focus on differentiated, mission-critical technology. The issue is scale. Kern is still modest relative to AMETEK's \u003cstrong\u003e$7.40B\u003c\/strong\u003e revenue base and \u003cstrong\u003e$55.30B\u003c\/strong\u003e market cap. AMETEK's 2025 acquisition spending totaled \u003cstrong\u003e$933.2M\u003c\/strong\u003e, and 2026 capex is about \u003cstrong\u003e$160M\u003c\/strong\u003e, so capital is being spread across multiple priorities. Without disclosed market share or growth data, Kern cannot be treated as a Cow or Star. It remains a Question Mark because the business may have strong technical value but has not yet shown enough scale.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapital allocation test:\u003c\/strong\u003e AMETEK is using cash to buy growth rather than waiting for organic expansion alone.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003ePortfolio test:\u003c\/strong\u003e these deals are meaningful only if they improve revenue quality, margins, and cash generation.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eExecution test:\u003c\/strong\u003e integration speed will decide whether these assets become stronger positions or stay small bets.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eAMETEK Data Point\u003c\/th\u003e\n\u003cth\u003eWhy It Matters for Question Marks\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$7.40B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows the size of the base that new acquisitions must scale into\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 market cap\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$55.30B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows financial capacity and investor expectations\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 acquisition spending\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$933.2M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows active portfolio reshaping through M\u0026amp;A\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 innovation spend increase\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$85.0M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows internal support for future product growth\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVitality index\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e26%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIndicates a meaningful flow of newer products into the portfolio\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 2026 orders\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.20B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSuggests the company has demand strength to absorb acquisitions\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecord backlog\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.87B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows future revenue visibility and integration runway\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\u003ch2\u003eAMETEK, Inc. - BCG Matrix Analysis: Dogs\u003c\/h2\u003e\n\n\u003cp\u003eAMETEK, Inc. does not show a clear, material dog segment in its public reporting as of June 2026. The company's latest results point to broad demand strength, high margins, and strong cash generation, which are not the signs of a low-growth, low-share business unit that drags on the portfolio.\u003c\/p\u003e\n\n\u003cp\u003eIn BCG Matrix terms, a dog is a business with weak market growth and weak relative market share. AMETEK's reported figures point in the opposite direction. 2025 sales rose \u003cstrong\u003e6.6%\u003c\/strong\u003e to \u003cstrong\u003e$7.40B\u003c\/strong\u003e, Q1 2026 sales rose \u003cstrong\u003e11.3%\u003c\/strong\u003e to \u003cstrong\u003e$1.93B\u003c\/strong\u003e, adjusted operating margin was \u003cstrong\u003e26.2%\u003c\/strong\u003e, and free cash flow conversion was \u003cstrong\u003e113%\u003c\/strong\u003e. Those are not the patterns you normally see in a business stuck in a dog quadrant.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eReported figure\u003c\/td\u003e\n\u003ctd\u003eWhat it suggests for BCG analysis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$7.40B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRevenue growth points away from a stagnant, low-growth dog profile\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 2026 sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.93B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQuarterly momentum supports a healthy portfolio position\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ1 2026 orders\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.20B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOrders above sales indicate demand visibility and pipeline support\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBacklog\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.87B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRecord backlog reduces the case for a declining unit\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdjusted operating margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e26.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStrong profitability suggests assets are not structurally impaired\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree cash flow conversion\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e113%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCash generation exceeds accounting profit, which weakens the dog thesis\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe backlog and order data matter because they show the business is supported by current and near-term demand. Q1 2026 organic orders grew \u003cstrong\u003e22%\u003c\/strong\u003e, total orders rose \u003cstrong\u003e23%\u003c\/strong\u003e, and backlog reached a record \u003cstrong\u003e$3.87B\u003c\/strong\u003e. Q1 2026 adjusted EPS increased to \u003cstrong\u003e$1.97\u003c\/strong\u003e. A dog usually has shrinking demand, weak pricing power, and limited reinvestment appeal. AMETEK's reported numbers do not fit that pattern.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eQ1 2026 orders of \u003cstrong\u003e$2.20B\u003c\/strong\u003e were above quarterly sales, which supports future revenue conversion.\u003c\/li\u003e\n \u003cli\u003eOrganic orders growing \u003cstrong\u003e22%\u003c\/strong\u003e shows demand strength without relying only on acquisitions.\u003c\/li\u003e\n \u003cli\u003eBacklog of \u003cstrong\u003e$3.87B\u003c\/strong\u003e gives the company a buffer against short-term softness.\u003c\/li\u003e\n \u003cli\u003eAdjusted EPS of \u003cstrong\u003e$1.97\u003c\/strong\u003e and adjusted operating margin of \u003cstrong\u003e26.2%\u003c\/strong\u003e indicate that current units are earning attractive returns.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eAMETEK's strategy also works against dog formation. The company focuses on operational excellence, strategic acquisitions, global expansion, and technology innovation. It targets niche markets with high barriers to entry and recurring revenue from consumables, services, and aftermarket support. That model usually protects share and pricing, which makes it harder for weak units to linger in the portfolio.\u003c\/p\u003e\n\n\u003cp\u003eThe company invested \u003cstrong\u003e$85.0M\u003c\/strong\u003e in innovation and market expansion during 2025 and plans about \u003cstrong\u003e$160M\u003c\/strong\u003e of capex in 2026. That spending pattern points toward growth and productivity, not toward keeping unproductive assets alive. In BCG terms, the capital is being directed toward businesses with better growth and return potential, not toward low-value holdings.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOperational excellence improves margins and lowers the chance that a business unit becomes a drag.\u003c\/li\u003e\n \u003cli\u003eAcquisitions shift capital into stronger niches rather than weak legacy assets.\u003c\/li\u003e\n \u003cli\u003eRecurring revenue from aftermarket service reduces cyclicality and supports retention.\u003c\/li\u003e\n \u003cli\u003eCapex focused on innovation and expansion helps preserve competitive position.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eCapital recycling further reduces the chance of a meaningful dog. AMETEK spent \u003cstrong\u003e$933.2M\u003c\/strong\u003e on acquisitions net of cash acquired in 2025 and announced more deals in 2026, including LKC, First Aviation, and the \u003cstrong\u003e$5.0B\u003c\/strong\u003e Indicor instrumentation agreement. It also paid down \u003cstrong\u003e$425M\u003c\/strong\u003e of debt maturities in 2025 while keeping investment-grade credit as a stated objective. This shows disciplined use of capital, with money moving toward higher-return assets and away from underperforming ones.\u003c\/p\u003e\n\n\u003cp\u003eFor valuation and strategy work, this matters because dogs can trap capital and depress returns on invested capital. AMETEK's market capitalization of about \u003cstrong\u003e$55.30B\u003c\/strong\u003e and institutional ownership of \u003cstrong\u003e87.43%\u003c\/strong\u003e suggest investors expect disciplined portfolio management, not long-term support for weak assets. That does not prove every unit is strong, but it does show the company is not publicly presenting a large weak segment.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapital allocation item\u003c\/td\u003e\n\u003ctd\u003eReported figure\u003c\/td\u003e\n\u003ctd\u003eBCG relevance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcquisitions net of cash acquired, 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$933.2M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSignals active redeployment into better growth platforms\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInnovation and market expansion spending, 2025\u003c\/td\u003e\n \u003ctd\u003e\u003cstrong\u003e$85.0M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSupports competitive strength instead of stagnation\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlanned capex, 2026\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$160M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eShows continued investment in operating capacity and technology\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDebt maturities paid in 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$425M\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIndicates balance sheet discipline, not cash drain from weak units\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eMarket confidence also argues against a large dog presence. BlackRock held about \u003cstrong\u003e18.83M\u003c\/strong\u003e shares, or \u003cstrong\u003e8.21%\u003c\/strong\u003e of the company, while insiders held only \u003cstrong\u003e0.66%\u003c\/strong\u003e. AMETEK's 2026 adjusted EPS guidance of \u003cstrong\u003e$7.94\u003c\/strong\u003e to \u003cstrong\u003e$8.14\u003c\/strong\u003e implies \u003cstrong\u003e7%\u003c\/strong\u003e to \u003cstrong\u003e10%\u003c\/strong\u003e growth, and sales guidance remains in the high single digits. The 2025 dividend increase of \u003cstrong\u003e10%\u003c\/strong\u003e to \u003cstrong\u003e$0.34\u003c\/strong\u003e per share also fits a company with a strong cash base.\u003c\/p\u003e\n\n\u003cp\u003eWhen you use BCG Matrix analysis in an academic paper, AMETEK is better discussed as a company with limited visible dog exposure rather than as a business with a clear dog category. The public data show growth, backlog support, strong margins, and active capital recycling, all of which reduce the case for a materially weak segment.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":44601010487445,"sku":"ame-bcg-matrix","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/ame-bcg-matrix.png?v=1740145912","url":"https:\/\/dcf-analysis.com\/products\/ame-bcg-matrix","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}